Summit Therapeutics plc (SMMT) Social Stream
Summit Therapeutics Inc (SMMT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SMMT.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
Over the past 148 days, SMMT's average price target has gone down $0.
Over the past 33 weeks, SMMT's average upside potential has been -34.85%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SMMT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SMMT has a higher number of analysts covering the stock than nearly none of all US stocks.
- In terms of how Summit Therapeutics Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than almost 100% of that group.
- In the context of stocks in the small market cap category, Summit Therapeutics Inc's average analyst price target is greater than nearly none of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Summit Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than nearly none of them.
Is SMMT a Buy, Hold or Sell? See the POWR Ratings now!